Crucial results for corona vaccination strategy

Empa researcher Peter Wick, Head of the Particles-Biology Interactions Laboratory in St. Gallen and Director of contactpointnano.ch talks to Empa Quarterly about recent antibody studies, which are crucial for the development of a COVID-19 vaccine, and the next generation of textile protective materials that inactivate or even kill corona viruses.

You can read the full article here.

Related articles

Subscribe to our newslett... Like to be kept up to date? Sign up to our bi-monthly newsletter here!
Webinar: Open questions a... Face masks characterize the public spaces today. Together with other measures, such as social distancing, hand hygiene and contact tracing, masks actively contribute to fight the spread
Need help with the regist... eREACHNano is a new free web tool focused on helping small and medium-sized companies that may lack sufficient in-house expertise on the regulation covering nanomaterials.
Reliable knowledge on nan... contactpointnano.ch helps with questions about nanomaterials A new contact point for start-ups, SMEs and industry bundles the scientific and regulatory expertise in the field of nanotechnology available
Publications on Synthetic... Action plan Synthetic Nanomaterials Report by the Federal Council of 9 April 2008 Synthetic Nanomaterials Risk Assessment and Risk ManagementBasic report for the Swiss Action Plan, 2007
Medical Device Regulation... Join us on December 14, 2020 for contactpointnano.ch‘s second webinar and learn about how to navigate new regulations for medical devices and new requirements regarding nanomaterials. Time: 13.00
Swiss NanoConvention 2020
Save the date: NME21 Due to the sanitary situation, Nanomed Europe 21 (NME21) is postponed to Tuesday, September 7 – Thursday, September 9, 2021, still in St. Gallen, Switzerland: www.nme21.eu Do not miss this
Biointerfaces
Questions about nanomater... New initiative to pool know-how on synthetic nanomaterials in Switzerland Hönggerberg, June 7, 2018 – At the Swiss Nano Convention 2018, taking place at ETH Zurich this